Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8701 to 8715 of 8852 results

  1. Heart failure patients to be remotely monitored by technology shown to cut hospitalisations by 50%

    Two technologies, HeartLogic and TriageHF, have been recommended in final diagnostic guidance.

  2. New Alzheimer's treatment donanemab does not currently demonstrate value for the NHS says NICE

    More evidence is needed on the clinical and cost-effectiveness of donanemab, a new treatment for mild Alzheimer’s disease.

  3. First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended by NICE

    For the first time, we have recommended a targeted treatment option for ALK-positive non-small-cell lung cancer, to be given after surgery to reduce the risk of the disease coming back.

  4. Consultation on NHS England proposals for a phased launch of obesity injection

    Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins.

  5. NICE ready to work with company to address uncertainty in evidence for elacestrant for advanced breast cancer

    Today (1 October 2024) NICE is consulting on draft guidance that does not recommend elacestrant for treating a type of advanced breast cancer.

  6. NICE Board says new method allowing greater weight to be given to severe diseases is working

    At today's meeting (25th September 2024) our board has concluded that the new severity modifier is working as intended.

  7. Adults with Von Hippel-Lindau disease to benefit from new treatment

    NICE has recommended belzutifan for some adults with Von Hippel-Lindau disease, in final draft guidance, which could benefit up to 100 people.

  8. Thousands could benefit from new option for treating symptoms of uterine fibroids

    As many as 30,000 adults could benefit from a new treatment for moderate to severe symptoms of uterine fibroids after we published final guidance today (14 August 2024) recommending linzagolix.

  9. New joint guideline recommends prescribing combination treatments for people with newly diagnosed asthma

    For the first time, the British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN) have collaborated to develop a UK-wide asthma guideline.

  10. Keep the size of your waist to less than half of your height, NICE recommends

    People are being encouraged to keep their waist measurement to less than half their height to reduce the risk of potential health problems.

  11. People who have had a stroke should be offered additional rehabilitation

    People who have had a stroke and who have continuing impairment or limitations on their activities should be offered additional rehabilitation to help them recover

  12. New drug approved for inherited clotting disorder, offering simpler dosing and enhanced quality of life.

    NICE publishes final draft guidance recommending efanesoctocog alfa as an option for treating and preventing bleeding in people aged 2 and over with severe haemophilia A.

  13. Three treatments for COVID-19 recommended in final draft guidance

    Everyone with COVID-19 at highest risk of developing severe disease will have access to clinically and cost-effective treatments.

  14. NICE signs up to join the GetReal Institute

    NICE and the GetReal Institute: facilitating the adoption and implementation of real-world evidence in health care decision-making.

  15. Supporting innovation: clear approval pathways and evidence standards for AI-driven digital health technologies

    Jeanette Kusel explains how we are working in partnership to improve patient access to the best digital health innovations.